Total submissions: 13
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Laboratory for Molecular Medicine, |
RCV000040188 | SCV000063879 | likely benign | not specified | 2015-03-11 | criteria provided, single submitter | clinical testing | p.Pro10595Thr in exon 156 of TTN: This variant is not expected to have clinical significance because it has been identified in 0.6% (101/16512) of South Asian c hromosomes by the Exome Aggregation Consortium (ExAC, http://exac.broadinstitute .org; dbSNP rs397517553). |
Eurofins Ntd Llc |
RCV000040188 | SCV000226382 | likely benign | not specified | 2014-12-23 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000040188 | SCV000236756 | benign | not specified | 2018-01-08 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Labcorp Genetics |
RCV000465574 | SCV000555570 | benign | Dilated cardiomyopathy 1G; Autosomal recessive limb-girdle muscular dystrophy type 2J | 2024-01-27 | criteria provided, single submitter | clinical testing | |
CHEO Genetics Diagnostic Laboratory, |
RCV001170386 | SCV001332963 | benign | Cardiomyopathy | 2017-12-08 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV001839597 | SCV002101244 | benign | Autosomal recessive limb-girdle muscular dystrophy type 2J | 2021-09-10 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV001839598 | SCV002101245 | benign | Myopathy, myofibrillar, 9, with early respiratory failure | 2021-09-10 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV001839599 | SCV002101246 | benign | Early-onset myopathy with fatal cardiomyopathy | 2021-09-10 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV001839596 | SCV002101248 | benign | Tibial muscular dystrophy | 2021-09-10 | criteria provided, single submitter | clinical testing | |
Fulgent Genetics, |
RCV002504909 | SCV002800356 | benign | Dilated cardiomyopathy 1G; Autosomal recessive limb-girdle muscular dystrophy type 2J; Tibial muscular dystrophy; Myopathy, myofibrillar, 9, with early respiratory failure; Early-onset myopathy with fatal cardiomyopathy; Hypertrophic cardiomyopathy 9 | 2021-08-13 | criteria provided, single submitter | clinical testing | |
Revvity Omics, |
RCV003137564 | SCV003823616 | uncertain significance | not provided | 2023-09-22 | criteria provided, single submitter | clinical testing | |
Ce |
RCV003137564 | SCV005075227 | likely benign | not provided | 2024-08-01 | criteria provided, single submitter | clinical testing | TTN: BP4 |
Prevention |
RCV004541150 | SCV004764028 | likely benign | TTN-related disorder | 2023-04-25 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |